Impact of Disease Modifying Therapies (DMTs) and Associated Support Services in Relapsing Multiple Sclerosis (RMS) Patients
Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The objective is to establish the impact of current disease modifying therapies (DMTs) and
associated support services on Patient Reported Experience Measures and Patient Reported
Outcomes in relation to the treatment and management of Relapsing Multiple Sclerosis in the
United Kingdom (UK).